TREATMENT WITH DECITABINE (DAC) INDUCES THE EXPRESSION OF STEMNESS MARKERS, PD-L1 AND NY-ESO-1 IN COLORECTAL CANCER

被引：0
|
作者：
Taib, Nassiba [1 ]
Merhi, Maysaloun [1 ]
Inchakalody, Varghese [1 ]
Mestiri, Sarra [1 ]
Raza, Afsheen [1 ]
Uddin, Shahab [1 ]
Maccalli, Cristina [2 ]
AlHomsi, Mohammed Ussama [1 ]
Dermime, Said [1 ]
机构：
[1] Hamad Med Corp, Doha, Qatar
[2] Sidra Med, Doha, Qatar
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
736
引用
收藏
页码：A767 / A767
页数：1
相关论文
共 50 条
  • [31] NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer
    Szender, J. B.
    Papanicolau-Sengos, A.
    Eng, K.
    Miliotto, A. J.
    Lugade, A.
    Gnjatic, S.
    Matsuzaki, J.
    Odunsi, K.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 30 - 30
  • [32] NY-ESO-1 antigen: A promising frontier in cancer immunotherapy
    Alsalloum, Alaa
    Shevchenko, Julia A.
    Sennikov, Sergey
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (09):
  • [33] A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression
    Gunda, Viswanath
    Frederick, Dennie T.
    Bernasconi, Maria J.
    Wargo, Jennifer A.
    Parangi, Sareh
    THYROID, 2014, 24 (08) : 1241 - 1250
  • [34] NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Roelands, Jessica
    Hendrickx, Wouter
    Dermime, Said
    Bedognetti, Davide
    Decock, Julie
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
    Endo, Makoto
    de Graaff, Marieke A.
    Ingram, Davis R.
    Lim, Simin
    Lev, Dina C.
    Riaire-de Bruijn, Inge H.
    Somaiah, Neeta
    Bovee, Judith V. M. G.
    Lazar, Alexander J.
    Nielseni, Torsten O.
    MODERN PATHOLOGY, 2015, 28 (04) : 587 - 595
  • [36] Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability
    Yu, Ganjun
    Wang, Wenying
    He, Xiaobo
    Xu, Jia
    Xu, Rongrong
    Wan, Tao
    Wu, Yanfeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] The expression of NY-ESO-1, cancer specific antigen, in patients with hepatocellular carcinoma.
    Nakamura, S
    Nouso, K
    Taniyama, M
    Kobayasi, Y
    Nakatsukasa, H
    Uemura, M
    Sato, S
    Yumoto, E
    Yokoyama, J
    Tsuboi, S
    Higashi, T
    Tsuji, T
    HEPATOLOGY, 2001, 34 (04) : 180A - 180A
  • [38] Cosmosiin Induces Apoptosis in Colorectal Cancer by Inhibiting PD-L1 Expression and Inducing ROS
    Han, Jung Ho
    Lee, Eun-Ji
    Park, Wonyoung
    Choi, Jang-Gi
    Ha, Ki-Tae
    Chung, Hwan-Suck
    Oliver, Jordi
    ANTIOXIDANTS, 2023, 12 (12)
  • [39] Prognostic value of MAGE-3 and NY-ESO-1 expression in pharyngeal cancer
    Sarcevic, B.
    Pastorcic-Grgic, M.
    Dosen, D.
    Knezevic, F.
    VIRCHOWS ARCHIV, 2009, 455 : 339 - 339
  • [40] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
    Yaghoubi, Neda
    Soltani, Arash
    Ghazvini, Kiarash
    Hassanian, Seyed Mahdi
    Hashemy, Seyed Isaac
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
12345